Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
Abstract Background Cell migration and invasion are essential processes for metastatic dissemination of cancer cells. Significant progress has been made in developing new therapies against oncogenic signaling to eliminate cancer cells and shrink tumors. However, inherent heterogeneity and treatment-...
Main Authors: | Pradip Shahi Thakuri, Megha Gupta, Sunil Singh, Ramila Joshi, Eric Glasgow, Alexander Lekan, Seema Agarwal, Gary D. Luker, Hossein Tavana |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-019-6479-2 |
Similar Items
-
Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
by: Liao Y, et al.
Published: (2018-09-01) -
MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study
by: Weihua Jiang, et al.
Published: (2021-05-01) -
Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway
by: Hao Wu, et al.
Published: (2021-02-01) -
HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer
by: Qinghua Liu, et al.
Published: (2021-01-01) -
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
by: Lei Zhang, et al.
Published: (2020-08-01)